Abstract
Purpose
Cardiovascular calcifications (CVC) are present in up to 70% of non-diabetic dialysis patients. Sparse data are available on predictors of very long-term outcomes of such patients. The Belgrade Aachen Study on Calcification in Hemodialysis patients (BASCH study) aimed to study this using a comprehensive CVC assessment.
Methods
We prospectively analyzed 220 hemodialysis patients followed for a mean of 76 months (median 73 months, range 6–160 months). We compared patients deceased from cardiovascular diseases (CVD) and survivors. Analyses included composite calcification scores (determined by combining ultrasound and X-ray analyses), demographic, clinical and laboratory data and pulse wave velocity (PWV). For survival analysis, patients were divided into group according to quartiles (Q).
Results
Compared to survivors, deceased patients from CVD were significantly older, more frequently hypertensive, had shorter dialysis times per week and lower Kt/V values, and they exhibited lower serum fetuin A, osteoprotegerin and hemoglobin as well as higher CRP levels. Composite calcification and Adragao scores were significantly higher in deceased patients from CVD as was PWV. Mean survival was 101 ± 47 months (Q1), 87 ± 51 month (Q2), 66 ± 48 (Q3) and 54 ± 45 months (Q4), p = 0.000. Cox multivariate regression analysis showed that independent predictors for cardiovascular mortality were composite calcification score in the range of third and fourth quartiles.
Conclusion
Composite calcification score emerged as significant predictors of long-term survival in our group of largely non-diabetic dialysis patient population, finding that should be confirmed by intervention studies.
Similar content being viewed by others
References
Schlieper G, Brandenburg V, Djuric Z et al (2009) Risk factors for cardiovascular calcifications in nondiabetic Caucasian haemodialysis patients. Kidney Blood Press Res 32:161–168
Ketteler M, Schlieper G, Floege J (2006) Calcification and cardiovascular health: new insights into an old phenomenon. Hypertension 47:1027–1034
Lanzer P, Boehm M, Sorribas V et al (2014) Medial vascular calcification revisited: review and perspectives. Eur Heart J 35:1515–1525
Brandenburg VM, Sinha S, Specht P et al (2014) Calcific uraemic arteriolopathy: a rare disease with a potentially high impact on chronic kidney disease mineral and bone disorder. Pediatr Nephrol 29:2289–2298
Raggi P, Boulay A, Scott CT et al (2002) Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease? J Am Coll Cardiol 39:695–701
London G, Covic A, Goldsmith D et al (2011) Arterial aging and arterial disease: interplay between central hemodynamics, cardiac work, and organ flow-implications for CKD and cardiovascular disease. Kidney Int Suppl 1:10–12
Yoon HE, Chung S, Whang HC, Shin YR et al (2012) Abdominal aortic calcification is associated with diastolic dysfunction, mortality, and nonfatal cardiovascular events in maintenance hemodialysis patients. J Korean Med Sci 27(8):870–875. https://doi.org/10.3346/jkms.2012.27.8.870
Kwon HY, Lee OH, Kim MJ et al (2014) The association between mortality and abdominal aortic calcification and relation between its progression and serum calcium concentration in chronic hemodialysis patients. Kidney Res Clin Pract 33(2):95–102. https://doi.org/10.1016/j.krcp.2014.04.003
Inoue H, Shimizu S, Watanabe K et al (2017) Impact of trajectories of abdominal aortic calcification over 2 years on subsequent mortality: a 10-year longitudinal study. Nephrol Dial Transplant. https://doi.org/10.1093/ndt/gfx253
Schlieper G, Krüger T, Djuric Z et al (2008) Vascular access calcification predict mortality in hemodialysis patients. Kidney Int 74(12):1582–1587. https://doi.org/10.1038/ki.2008.458
Hong D, Wu S, Pu L et al (2013) Abdominal aortic calcification is not superior over other vascular calcification in predicting mortality in hemodialysis patients: a retrospective observational study. BMC Nephrol 14:120. https://doi.org/10.1186/1471-2369-14-120
Adragao T, Pires A, Lucas C et al (2004) A simple vascular calcification score predicts cardiovascular risk in haemodialysis patients. Nephrol Dial Transplant 19:1480–1488
Damjanovic T, Djuric Z, Markovic N, Dimković S, Radojcic Z, Dimkovic N (2009) Screening of vascular calcifications in patients with end-stage renal diseases. Gen Physiol Biophys 28:277–283
Ix JH, Shlipak MG, Brandenburg VM et al (2006) Association between human fetuin-A and the metabolic syndrome: data from the heart and soul study. Circulation 113:1760–1767
Schurgers LJ, Teunissen KJ, Knapen MH et al (2005) Novel conformation-specific antibodies against matrix gamma-carboxyglutamic acid (Gla) protein: undercarboxylated matrix Gla protein as marker for vascular calcification. Arterioscler Thromb Vasc Biol 25:1629–1633
Schlieper G (2014) Vascular calcification in chronic kidney disease: not all arteries are created equal. Kidney Int 85:501–503
Floege J, Gillespie IA, Kronenberg F et al (2015) Development and validation of a predictive morality risk score from a European hemodialysis cohort. Kidney Int 87(5):996–1008
Anker SD, Gillespie IA, Eckardt KU, On behalf the ARO Steering Committee (collaborators) et al (2016) Development and validation of cardiovascular risk scores for hemodialysis patients. Int J Cardiol 216:68–77
Haydar AA, Covic A, Colhoun H, Rubens M, Goldsmith DJ (2004) Coronary artery calcification and aortic pulse wave velocity in chronic kidney disease patients. Kidney Int 65:1790–1794
Blacher J, Guerin AP, Pannier B, Marchais SJ, London GM (2001) Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 38:938–942
Zoccali C, London G (2015) Con: vascular calcification is a surrogate marker, but not the cause of ongoing vascular disease, and it is not a treatment target in chronic kidney disease. Nephrol Dial Transplant 30:352–357
Brandenburg VM, Sinha S, Specht P, Kettelr M (2014) Calcific uraemic arteriolopathy: a rare disease with a potentially high impact on chronic kidney disease-mineral and bone disorder. Pediatr Nephrol 29(12):2289–2298. https://doi.org/10.1007/s00467-013-2746-7
Bover J, Evenepoel P, Urena’Tores P et al (2015) Pro: cardiovascular calcifications are clinically relevant. Nephrol Dial Transplant 30(3):345–351. https://doi.org/10.1093/ndt/gfv020
Ketteler M, Rothe K, Kruger T et al (2011) Mechanisms and treatment of extraosseous calcification in chronic kidney disease. Nat Rev Nephrol 7:509–5016
Schafer C, Heiss A, Schwarz A et al (2003) The serum protein alpha 2-Heremans–Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest 112:357–366
Dautova Y, Kozlova D, Skepper JN et al (2014) Fetuin-A and albumin alter cytotoxic effects of calcium phosphate nanoparticles on human vascular smooth muscle cells. PLoS ONE 9(5):e97565. https://doi.org/10.1371/journal.pone.0097565 eCollection 2014
Ketteler M, Bongartz P, Westenfeld R et al (2003) Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study. Lancet 361(9360):827–833
Ix JH, Chertow GM, Shlipak MG et al (2007) Association of fetuin-A with mitral annular calcification and aortic stenosis among persons with coronary heart disease: data from the heart and soul study. Circulation 115:2533–2539
Moe SM, Reslerova M, Ketteler M et al (2005) Role of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease (CKD). Kidney Int 67:2295–2304
Cranenburg EC, Brandenburg VM, Vermeer C et al (2009) Uncarboxylated matrix Gla protein (ucMGP) is associated with coronary artery calcification in haemodialysis patients. Thromb Haemost 101:359–366
Schlieper G, Westenfeld R, Krüger T et al (2011) Circulating nonphosphorylated carboxylated matrix Gla protein predicts survival in ESRD patients. J Am Soc Nephrol 22:387–395
Kapustin AN, Davies JD, Reynolds JL et al (2011) Calcium regulates key components of vascular smooth muscle cells-derived matrix vesicles to enhance mineralization. Circ Res 109:e1–e12
Hofbauer LC, Schoppet M (2001) Osteoprotegerin: a link between osteoporosis and arterial calcification? Lancet 358:257–259
Eknoyan G, Beck GJ, Cheung AK et al (2002) Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 347(25):2010–2019
Schlieper G, Brandenburg V, Djuric Z et al (2007) Is there a correlation between C-reactive protein and calcification inhibitors with cardiovascular parameters and risk factors in hemodialysis patients? Dtsch Med Wochenschr 132:1820–1824
Floege J, Kim J, Ireland E et al (2011) Serum iPTH, calcium and phosphate, and the risk of mortality in a European hemodialysis population. Nephrol Dial Transplant 26:1948–1955
Davenport A (2015) Will incremental hemodialysis preserve residual renal function and improve patient survival? Semin Dial 28(1):16–19. https://doi.org/10.1111/sdi.12320
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Dimkovic, N., Schlieper, G., Jankovic, A. et al. Prognostic value of cardiovascular calcifications in hemodialysis patients: a longitudinal study. Int Urol Nephrol 50, 939–946 (2018). https://doi.org/10.1007/s11255-018-1821-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-018-1821-1